Fas and Fas Ligand Expression as Predictors of Liver Cancer Recurrence
Author Information
Author(s): Ito Y, Monden M, Takeda T, Eguchi H, Umeshita K, Nagano H, Nakamori S, Dono K, Sakon M, Nakamura M, Tsujimoto M, Nakahara M, Nakao K, Yokosaki Y, Matsuura N
Primary Institution: Osaka University Medical School
Hypothesis
The expression levels of Fas and Fas ligand can predict the recurrence of hepatocellular carcinoma.
Conclusion
The study found that Fas and Fas ligand expression levels are significant prognostic markers for disease-free survival in hepatocellular carcinoma patients.
Supporting Evidence
- Fas expression in HCC cells was significantly decreased in cases with poor differentiation.
- Fas L expression in carcinoma cells was observed exclusively in moderately or poorly differentiated cases.
- Each factor had prognostic significance for disease-free survival.
Takeaway
This study shows that measuring certain proteins in liver cancer cells can help doctors predict if the cancer will come back.
Methodology
The study investigated Fas and Fas ligand expression in 103 hepatocellular carcinoma samples using immunohistochemistry.
Statistical Information
P-Value
p<0.0001, p=0.0058, p=0.0222, p=0.0027
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website